Medical Condition News

RSS

'Love hormone' could hold key to treating drug addicts, say experts

Experts say oxytocin, a key hormone made naturally by the brain, could hold the key to treating drug addicts and help them avoid relapse.

12 Apr 2017

Physical activity linked to better chances of survival after heart attack

Exercise is associated with improved survival after a heart attack, according to research published today in the European Journal of Preventive Cardiology. The chances of survival increased as the amount of exercise rose.

12 Apr 2017

Researchers identify three novel genetic mutations linked to Fuchs dystrophy

Researchers discovered three novel genetic mutations associated with Fuchs endothelial corneal dystrophy, the most common corneal disorder requiring transplantation.

12 Apr 2017

Prevention, not cure, may be key to stopping Alzheimer’s disease

It has been 111 years since Auguste D. became the first person described with what is now called Alzheimer's disease.

12 Apr 2017

MUSC researchers provide first systemic evidence for safe use of tPA in stroke patients with SCD

Adult patients with sickle cell disease (SCD) who experience a stroke caused by a clot (i.e., ischemic strokes or IS) can be treated safely with tissue plasminogen activator (tPA) if they qualify, report investigators at the Medical University of South Carolina and elsewhere in the March 2017 issue of Stroke.

12 Apr 2017

Study may provide insight into how R-LA promotes death of hepatoma cells

A new study that measured metabolite levels over time in starved rat liver cancer cells showed that treatment with a form of alpha-lipoic acid (LA) inhibited glucose uptake and glycolysis, and led to decreased cellular glucose production from non-carbohydrate sources, which may help explain how the naturally occurring R enantiomeric form of LA (R-LA) promotes the death of hepatoma cells.

12 Apr 2017

Point/Counterpoint: Experts debate how to control exploding opioid epidemic

Two experts with opposing views squared off on the hotly debated topic of how best to control the exploding opioid epidemic in the U.S.- with increasing regulation of physician prescribing practices or by better educating patients and doctors.

12 Apr 2017

Disability simulations do more harm than good, study reveals

Professionals in the fields of education and rehabilitation psychology have long used disability simulations to try to promote understanding and improve attitudes about persons with disabilities.

12 Apr 2017

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

Researchers from the Indiana University Center for Aging Research and the Regenstrief Institute have performed the first study conducted in the United States under real-world conditions comparing patient adherence and tolerability to a class of drugs known as cholinesterase inhibitors.

11 Apr 2017

PID1 gene increases killing effect of chemotherapy drugs on brain tumor cells

Investigators at The Saban Research Institute of Children's Hospital Los Angeles have found that the gene PID1 enhances killing of medulloblastoma and glioblastoma cells.

11 Apr 2017

Researchers use genetic manipulation to regenerate auditory hair cells in adult mice

In an apparent first, St. Jude Children's Research Hospital investigators have used genetic manipulation to regenerate auditory hair cells in adult mice. The research marks a possible advance in treatment of hearing loss in humans. The study appears today in the journal Cell Reports.

11 Apr 2017

Scientists discover novel therapeutic target for retinal neovascularization

A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy).

11 Apr 2017

FDA grants approval for first drug to treat adults with tardive dyskinesia

The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.

11 Apr 2017

New nanowire technology may serve as platform to screen drugs for neurological diseases

A team led by engineers at the University of California San Diego has developed nanowires that can record the electrical activity of neurons in fine detail.

11 Apr 2017

Feinstein Institute research may lead to new treatment option for low-grade gliomas

Marc Symons, PhD, professor in The Feinstein Institute for Medical Research's Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers.

11 Apr 2017

Duke researchers link specific differences in brain structure to multiple forms of mental disorder

A Duke University study is the first to link specific differences in brain structure to what is common across many types of mental illness.

11 Apr 2017

Western-led research uncovers underlying molecular mechanism that controls acoustic habituation

Most people will startle when they hear an unexpected loud sound. The second time they hear the noise, they'll startle significantly less; by the third time, they'll barely startle at all.

11 Apr 2017

JAX professor receives grant from National Eye Institute to study diseases of retinal pigment epithelium

The National Eye Institute has awarded Jackson Laboratory Professor Patsy Nishina, Ph.D., and Associate Professor Gregory Carter, Ph.D., a four-year grant totaling $2,414,304 to study diseases of the retinal pigment epithelium (RPE), with the goal of identifying druggable targets for age-related macular degeneration and other heritable retinal diseases.

11 Apr 2017

Researchers design first light-activated drug for treatment of pain

A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug -the JF-NP-26, for the treatment of pain, according to a research with animal models published in the journal eLife.

11 Apr 2017

Metabolite produced by intestinal bacteria protects against type 2 diabetes, study shows

A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and its production is boosted by a fibre-rich diet.

11 Apr 2017

Medical Condition News

'Love hormone' could hold key to treating drug addicts, say experts

Physical activity linked to better chances of survival after heart attack

Researchers identify three novel genetic mutations linked to Fuchs dystrophy

Prevention, not cure, may be key to stopping Alzheimer’s disease

MUSC researchers provide first systemic evidence for safe use of tPA in stroke patients with SCD

Study may provide insight into how R-LA promotes death of hepatoma cells

Point/Counterpoint: Experts debate how to control exploding opioid epidemic

Disability simulations do more harm than good, study reveals

Researchers explore patient adherence, tolerability to class of Alzheimer's drugs

PID1 gene increases killing effect of chemotherapy drugs on brain tumor cells

Researchers use genetic manipulation to regenerate auditory hair cells in adult mice

Scientists discover novel therapeutic target for retinal neovascularization

FDA grants approval for first drug to treat adults with tardive dyskinesia

New nanowire technology may serve as platform to screen drugs for neurological diseases

Feinstein Institute research may lead to new treatment option for low-grade gliomas

Duke researchers link specific differences in brain structure to multiple forms of mental disorder

Western-led research uncovers underlying molecular mechanism that controls acoustic habituation

JAX professor receives grant from National Eye Institute to study diseases of retinal pigment epithelium

Researchers design first light-activated drug for treatment of pain

Metabolite produced by intestinal bacteria protects against type 2 diabetes, study shows

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News